Matches in Wikidata for { <http://www.wikidata.org/entity/Q91046246> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91046246 description "article scientifique publié en 2019" @default.
- Q91046246 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91046246 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91046246 description "scientific article published on 01 October 2019" @default.
- Q91046246 description "wetenschappelijk artikel" @default.
- Q91046246 description "наукова стаття, опублікована 1 жовтня 2019" @default.
- Q91046246 name "Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain" @default.
- Q91046246 name "Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain" @default.
- Q91046246 type Item @default.
- Q91046246 label "Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain" @default.
- Q91046246 label "Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain" @default.
- Q91046246 prefLabel "Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain" @default.
- Q91046246 prefLabel "Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain" @default.
- Q91046246 P1433 Q91046246-E33C2B4B-8E72-4AEC-AF80-B3D737B01469 @default.
- Q91046246 P1476 Q91046246-8A17DAD9-A5B1-4001-AC81-7664EC6E87BA @default.
- Q91046246 P2093 Q91046246-09384460-3B46-4F54-9539-A324205CEAC9 @default.
- Q91046246 P2093 Q91046246-916D430F-5D9A-4414-9740-BC8D6717FB4A @default.
- Q91046246 P2093 Q91046246-C5EB81E3-EFE8-41C5-8E4E-6FCC107BEEC4 @default.
- Q91046246 P2093 Q91046246-CDD01D6D-EF38-4568-BE1A-4FE0EF285460 @default.
- Q91046246 P304 Q91046246-B65E5A3E-99A4-4328-BD7F-55DFFFC01617 @default.
- Q91046246 P31 Q91046246-07E93FB8-B929-4C06-BB3C-D4697FF72A5C @default.
- Q91046246 P356 Q91046246-F7D6D221-8C6D-4FBF-A132-9F88F57EA2C8 @default.
- Q91046246 P433 Q91046246-4762C232-C73B-489B-9D4C-57A42AEBCFEB @default.
- Q91046246 P478 Q91046246-CD074EF9-51AD-49F2-A07D-30D9D656263E @default.
- Q91046246 P577 Q91046246-820F0F4F-C7CC-4619-98E5-C519CA87FBF7 @default.
- Q91046246 P698 Q91046246-B3EDBB7E-4660-435A-8BCC-3C4DA3F5378C @default.
- Q91046246 P921 Q91046246-C42881EA-4EC7-47DA-AC47-72FA327DC63C @default.
- Q91046246 P932 Q91046246-1AB3B406-CAA9-4E54-B405-E7B6028150BB @default.
- Q91046246 P356 IJPC.IJPC_41_19 @default.
- Q91046246 P698 31673220 @default.
- Q91046246 P1433 Q15710015 @default.
- Q91046246 P1476 "Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain" @default.
- Q91046246 P2093 "Abhijit S Nair" @default.
- Q91046246 P2093 "Basanth Kumar Rayani" @default.
- Q91046246 P2093 "Kodisharapu Praveen Kumar" @default.
- Q91046246 P2093 "Srinivasa Shyam Prasad Mantha" @default.
- Q91046246 P304 "595-596" @default.
- Q91046246 P31 Q13442814 @default.
- Q91046246 P356 "10.4103/IJPC.IJPC_41_19" @default.
- Q91046246 P433 "4" @default.
- Q91046246 P478 "25" @default.
- Q91046246 P577 "2019-10-01T00:00:00Z" @default.
- Q91046246 P698 "31673220" @default.
- Q91046246 P921 Q1088113 @default.
- Q91046246 P932 "6812433" @default.